JNK signaling is converted from anti- to pro-tumor pathway by Ras-mediated switch of Warts activity

Developmental Biology

Volumn 403, Issue 2, 2015, Pages 162-171

  Enomoto, Masato ^a   Kizawa, Daisuke ^a   Ohsawa, Shizue ^a   Igaki, Tatsushi ^a,b  

^a KYOTO UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Hippo signaling; JNK; Ras; Tumor progression

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; F ACTIN; LIM PROTEIN; PROTEIN AJUBA; PROTEIN SERINE THREONINE KINASE; PROTEIN WARTS; PROTEIN YORKIE; RAS PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; DROSOPHILA PROTEIN; HPO PROTEIN, DROSOPHILA; NUCLEAR PROTEIN; PROTEIN KINASE; SIGNAL PEPTIDE; TRANSACTIVATOR PROTEIN; WARTS PROTEIN, DROSOPHILA; YORKIE PROTEIN, DROSOPHILA;

ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CLONE; CONTROLLED STUDY; DROSOPHILA; EPITHELIUM; HISTOLOGY; IMAGO; LARVA; MUTANT; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TISSUE GROWTH; TUMOR GROWTH; ANIMAL; DROSOPHILA MELANOGASTER; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; IMAGINAL DISC; METABOLISM; NEOPLASM;

ANIMALS; DROSOPHILA MELANOGASTER; DROSOPHILA PROTEINS; HUMANS; IMAGINAL DISCS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MAP KINASE SIGNALING SYSTEM; NEOPLASMS; NUCLEAR PROTEINS; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; RAS PROTEINS; TRANS-ACTIVATORS;

EID: 84931576930     PISSN: 00121606     EISSN: 1095564X     Source Type: Journal    
DOI: 10.1016/j.ydbio.2015.05.001     Document Type: Article

References (90)

1. Antonyak M.A., Kenyon L.C., Godwin A.K., James D.C., Emlet D.R., Okamoto I., Tnani M., Holgado-Madruga M., Moscatello D.K., Wong A.J. Elevated JNK activation contributes to the pathogenesis of human brain tumors. Oncogene 2002, 21:5038-5046.
2. Arteaga C.L., Engelman J.A. ERBB receptors: from oncogene discovery to basic science to mechanism-based cancer therapeutics. Cancer Cell 2014, 25:282-303.
3. Biteau B., Jasper H. EGF signaling regulates the proliferation of intestinal stem cells in Drosophila. Development 2011, 138:1045-1055.
4. Bode A.M., Dong Z. The functional contrariety of JNK. Mol. Carcinog. 2007, 46:591-598.
5. Borkham-Kamphorst E., van Roeyen C.R.C., Ostendorf T., Floege J., Gressner A.M., Weiskirchen R. Pro-fibrogenic potential of PDGF-D in liver fibrosis. J. Hepatol. 2007, 46:1064-1074.
6. Bost F., McKay R., Dean N., Mercola D. The JUN kinase/Stress-activated protein kinase pathway Is required for epidermal growth factor stimulation of growth of human A549 lung carcinoma cells. J. Biol. Chem. 1997, 272:33422-33429.
7. Brumby A.M., Goulding K.R., Schlosser T., Loi S., Galea R., Khoo P., Bolden J.E., Aigaki T., Humbert P.O., Richardson H.E. Identification of novel Ras-cooperating oncogenes in Drosophila melanogaster: a RhoGEF/Rho-Family/JNK pathway is a central driver of tumorigenesis. Genetics 2011, 188:105-125.
8. Brumby A.M., Richardson H.E. Scribble mutants cooperate with oncogenic Ras or Notch to cause neoplastic overgrowth in Drosophila. EMBO J. 2003, 22:5769-5779.
9. Bubici C., Papa S. JNK signalling in cancer: in need of new, smarter therapeutic targets. Br. J. Pharmacol. 2014, 171:24-37.
10. Bunker B.D., Nellimoottil T.T., Boileau R.M., Classen A.K., Bilder D. The transcriptional response to tumorigenic polarity loss in Drosophila. eLIFE 2015, 4:e03189.
11. Cellurale C., Sabio G., Kennedy N.J., Das M., Barlow M., Sandy P., Jacks T., Davis R.J. Requirement of c-Jun NH2-terminal kinase for Ras-initiated tumor formation. Mol. Cell. Biol. 2011, 31:1565-1576.
12. Cellurale C., Weston C.R., Reilly J., Garlick D.S., Jerry D.J., Sluss H.K., Davis R.J. Role of JNK in a Trp53-dependent mouse model of breast cancer. PLoS ONE 2010, 5:e12469.
13. Chen C.L., Gajewski K.M., Hamaratoglu F., Bossuyt W., Sansores-Garcia L., Tao C., Halder G. The apical-basal cell polarity determinant Crumbs regulates Hippo signaling in Drosophila. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:15810-15815.
14. Chen C.L., Schroeder M.C., Kango-Singh M., Tao C., Halder G. Tumor suppression by cell competition through regulation of the Hippo pathway. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:484-489.
15. Chi C., Zhu H., Han M., Zhuang Y., Wu X., Xu T. Disruption of lysosome function promotes tumor growth and metastasis in Drosophila. J. Biol. Chem. 2010, 285:21817-21823.
16. Christofori G. New signals from the invasive front. Nature 2006, 441:444-450.
17. Ciardiello F., Tortora G. EGFR antagonists in cancer treatment. N. Engl. J. Med. 2008, 358:1160-1174.
18. Das Thakur M., Feng Y., Jagannathan R., Seppa M.J., Skeath J.B., Longmore G.D. Ajuba LIM proteins are negative regulators of the Hippo signaling pathway. Curr. Biol. 2010, 20:657-662.
19. Doggett K., Grusche F., Richardson H., Brumby A. Loss of the Drosophila cell polarity regulator Scribbled promotes epithelial tissue overgrowth and cooperation with oncogenic Ras-Raf through impaired Hippo pathway signaling. BMC Dev. Biol. 2011, 11:57.
20. Dong J., Feldmann G., Huang J., Wu S., Zhang N., Comerford S.A., Gayyed M.F., Anders R.A., Maitra A., Pan D. Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 2007, 130:1120-1133.
21. Downward J. Targeting RAS signalling pathways in cancer therapy. Nat. Rev. Cancer 2003, 3:11-22.
22. Drees F., Pokutta S., Yamada S., Nelson W.J., Weis W.I. α-Catenin is a molecular switch that binds E-Cadherin-β-Catenin and regulates Actin-filament assembly. Cell 2005, 123:903-915.
23. Enderle L., McNeill H. Hippo gains weight: added insights and complexity to pathway control. Sci. Signal. 2013, 6:re7.
24. Enomoto M., Igaki T. Deciphering tumor-suppressor signaling in flies: genetic link between Scribble/Dlg/Lgl and the Hippo pathways. J. Genet. Genom. 2011, 38:461-470.
25. Enomoto M., Igaki T. Src controls tumorigenesis via JNK-dependent regulation of the Hippo pathway in Drosophila. EMBO Rep. 2013, 14:65-72.
26. Fernández B.G., Gaspar P., Brás-Pereira C., Jezowska B., Rebelo S.R., Janody F. Actin-Capping Protein and the Hippo pathway regulate F-actin and tissue growth in Drosophila. Development 2011, 138:2337-2346.
27. Fernandez B.G., Jezowska B., Janody F. Drosophila actin-Capping Protein limits JNK activation by the Src proto-oncogene. Oncogene 2014, 33:2027-2039.
28. Gonzalez C. Drosophila melanogaster: a model and a tool to investigate malignancy and identify new therapeutics. Nat. Rev. Cancer 2013, 13:172-183.
29. Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E., deFazio A., Greaves M.F., Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R. Patterns of somatic mutation in human cancer genomes. Nature 2007, 446:153-158.
30. Grusche F.A., Degoutin J.L., Richardson H.E., Harvey K.F. The Salvador/Warts/Hippo pathway controls regenerative tissue growth in Drosophila melanogaster. Dev. Biol. 2011, 350:255-266.
31. Hübner A., Mulholland D.J., Standen C.L., Karasarides M., Cavanagh-Kyros J., Barrett T., Chi H., Greiner D.L., Tournier C., Sawyers C.L., Flavell R.A., Wu H., Davis R.J. JNK and PTEN cooperatively control the development of invasive adenocarcinoma of the prostate. Proc. Natl. Acad. Sci. U.S.A 2012, 109:12046-12051.
32. Halder G., Johnson R.L. Hippo signaling: growth control and beyond. Development 2011, 138:9-22.
33. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
34. Herz H.M., Chen Z., Scherr H., Lackey M., Bolduc C., Bergmann A. vps25 mosaics display non-autonomous cell survival and overgrowth, and autonomous apoptosis. Development 2006, 133:1871-1880.
35. Hirabayashi S., Baranski T.J., Cagan R.L. Transformed Drosophila Cells Evade Diet-Mediated Insulin Resistance through Wingless Signaling. Cell 2013, 154:664-675.
36. Huang C., Jacobson K., Schaller M.D. MAP kinases and cell migration. J. Cell Sci. 2004, 117:4619-4628.
37. Hui L., Zatloukal K., Scheuch H., Stepniak E., Wagner E.F. Proliferation of human HCC cells and chemically induced mouse liver cancers requires JNK1-dependent p21 downregulation. J. Clin. Investig. 2008, 118:3943-3953.
38. Igaki T., Kanda H., Yamamoto-Goto Y., Kanuka H., Kuranaga E., Aigaki T., Miura M. Eiger, a TNF superfamily ligand that triggers the Drosophila JNK pathway. EMBO J. 2002, 21:3009-3018.
39. Igaki T., Miura M. The Drosophila TNF ortholog Eiger: Emerging physiological roles and evolution of the TNF system. Semin. Immunol. 2014, 26:267-274.
40. Igaki T., Pagliarini R.A., Xu T. Loss of cell polarity drives tumor growth and invasion through JNK activation in Drosophila. Curr. Biol. 2006, 16:1139-1146.
41. Igaki T., Pastor-Pareja J.C., Aonuma H., Miura M., Xu T. Intrinsic Tumor Suppression and Epithelial Maintenance by Endocytic Activation of Eiger/TNF Signaling in Drosophila. Dev. Cell 2009, 16:458-465.
42. Irvine K.D. Integration of intercellular signaling through the Hippo pathway. Semin. Cell Dev. Biol. 2012, 23:812-817.
43. Kanda H., Igaki T., Okano H., Miura M. Conserved metabolic energy production pathways govern Eiger/TNF-induced nonapoptotic cell death. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:18977-18982.
44. Kapoor A., Yao W., Ying H., Hua S., Liewen A., Wang Q., Zhong Y., Wu C.-J., Sadanandam A., Hu B., Chang Q., Chu G.C., Al-Khalil R., Jiang S., Xia H., Fletcher-Sananikone E., Lim C., Horwitz G.I., Viale A., Pettazzoni P., Sanchez N., Wang H., Protopopov A., Zhang J., Heffernan T., Johnson R.L., Chin L., Wang Y.A., Draetta G., DePinho R.A. Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer. Cell 2014, 158:185-197.
45. Karin M., Gallagher E. From JNK to pay dirt: Jun kinases, their biochemistry, physiology and clinical importance. IUBMB Life 2005, 57:283-295.
46. Karnoub A.E., Weinberg R.A. Ras oncogenes: split personalities. Nat. Rev. Mol. Cell Biol. 2008, 9:517-531.
47. Leong G., Goulding K., Amin N., Richardson H., Brumby A. Scribble mutants promote aPKC and JNK-dependent epithelial neoplasia independently of Crumbs. BMC Biol. 2009, 7:62.
48. Linardou H., Dahabreh I.J., Bafaloukos D., Kosmidis P., Murray S. Somatic EGFR mutations and efficacy of tyrosine kinase inhibitors in NSCLC. Nat. Rev. Clin. Oncol. 2009, 6:352-366.
49. Marie H., Pratt S.J., Betson M., Epple H., Kittler J.T., Meek L., Moss S.J., Troyanovsky S., Attwell D., Longmore G.D., Braga V.M.M. The LIM protein Ajuba is recruited to cadherin-dependent cell junctions through an association with α-catenin. J. Biol. Chem. 2003, 278:1220-1228.
50. Mattila J., Omelyanchuk L., Kyttälä S., Turunen H., Nokkala S. Role of Jun N-terminal Kinase (JNK) signaling in the wound healing and regeneration of a Drosophila melanogaster wing imaginal disc. Int. J. Dev. Biol. 2005, 49:391-399.
51. Menéndez J., Pérez-Garijo A., Calleja M., Morata G. A tumor-suppressing mechanism in Drosophila involving cell competition and the Hippo pathway. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:14651-14656.
52. Miles W.O., Dyson N.J., Walker J.A. Modeling tumor invasion and metastasis in Drosophila. Dis. Model. Mech. 2011, 4:753-761.
53. Moreno E., Yan M., Basler K. Evolution of TNF signaling mechanisms: JNK-dependent apoptosis triggered by Eiger, the Drosophila homolog of the TNF superfamily. Curr. Biol. 2002, 12:1263-1268.
54. Nola S., Daigaku R., Smolarczyk K., Carstens M., Martin-Martin B., Longmore G., Bailly M., Braga V.M.M. Ajuba is required for Rac activation and maintenance of E-cadherin adhesion. J. Cell Biol. 2011, 195:855-871.
55. Oh H., Irvine K.D. In vivo regulation of Yorkie phosphorylation and localization. Development 2008, 135:1081-1088.
56. Oh H., Irvine K.D. In vivo analysis of Yorkie phosphorylation sites. Oncogene 2009, 28:1916-1927.
57. Ohsawa S., Sato Y., Enomoto M., Nakamura M., Betsumiya A., Igaki T. Mitochondrial defect drives non-autonomous tumour progression through Hippo signalling in Drosophila. Nature 2012, 490:547-551.
58. Ohsawa S., Takemoto D., Igaki T. Dissecting tumour heterogeneity in flies: genetic basis of interclonal oncogenic cooperation. J. Biochem. 2014, 156:129-136.
59. Pan D. The Hippo signaling pathway in development and cancer. Dev. Cell 2010, 19:491-505.
60. Pastor-Pareja J.C., Xu T. Dissecting social cell biology and tumors using Drosophila genetics. Annu. Rev. Genet. 2013, 47:51-74.
61. Patel P.H., Edgar B.A. Tissue design: how Drosophila tumors remodel their neighborhood. Semin. Cell Dev. Biol. 2014, 28:86-95.
62. Pratt S.J., Epple H., Ward M., Feng Y., Braga V.M., Longmore G.D. The LIM protein Ajuba influences p130Cas localization and Rac1 activity during cell migration. J. Cell Biol. 2005, 168:813-824.
63. Rauskolb C., Pan G., Reddy B.V.V.G., Oh H., Irvine K.D. Zyxin links Fat signaling to the Hippo pathway. PLoS Biol. 2011, 9:e1000624.
64. Rauskolb C., Sun S., Sun G., Pan Y., Irvine K.D. Cytoskeletal tension inhibits Hippo signaling through an Ajuba-Warts complex. Cell 2014, 158:143-156.
65. Reddy B.V.V.G., Irvine K.D. Regulation of Hippo signaling by EGFR-MAPK signaling through Ajuba family proteins. Dev. Cell 2013, 24:459-471.
66. Ren F., Zhang L., Jiang J. Hippo signaling regulates Yorkie nuclear localization and activity through 14-3-3 dependent and independent mechanisms. Dev. Biol. 2010, 337:303-312.
67. Rincón M., Davis R.J. Regulation of the immune response by stress-activated protein kinases. Immunol. Rev. 2009, 228:212-224.
68. Robinson B.S., Moberg K.H. Drosophila endocytic neoplastic tumor suppressor genes regulate Sav/Wts/Hpo signaling and the c-Jun N-terminal kinase pathway. Cell Cycle 2011, 10:4110-4118.
69. Sakurai T., Maeda S., Chang L., Karin M. Loss of hepatic NF-κB activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:10544-10551.
70. Sansores-Garcia L., Bossuyt W., Wada K.-I., Yonemura S., Tao C., Sasaki H., Halder G. Modulating F-actin organization induces organ growth by affecting the Hippo pathway. EMBO J. 2011, 30:2325-2335.
71. Shao D.D., Xue W., Krall E.B., Bhutkar A., Piccioni F., Wang X., Schinzel A.C., Sood S., Rosenbluh J., Kim J.W., Zwang Y., Roberts T.M., Root D.E., Jacks T., Hahn W.C. KRAS and YAP1 converge to regulate EMT and tumor survival. Cell 2014, 158:171-184.
72. She Q.B., Chen N., Bode A.M., Flavell R.A., Dong Z. Deficiency of c-Jun-NH2-terminal kinase-1 in mice enhances skin tumor development by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res. 2002, 62:1343-1348.
73. Sofroniew M.V., Howe C.L., Mobley W.C. Nerve growth factor signaling, neuroprotection, and neural repair. Annu. Rev. Neurosci. 2001, 24:1217-1281.
74. Sun G., Irvine K.D. Regulation of Hippo signaling by Jun kinase signaling during compensatory cell proliferation and regeneration, and in neoplastic tumors. Dev. Biol. 2011, 350:139-151.
75. Sun G., Irvine K.D. Ajuba family proteins link JNK to Hippo signaling. Sci. Signal. 2013, 6:ra81.
76. Takino K., Ohsawa S., Igaki T. Loss of Rab5 drives non-autonomous cell proliferation through TNF and Ras signaling in Drosophila. Dev. Biol. 2014, 395:19-28.
77. Thomas C., Strutt D. Rabaptin-5 and Rabex-5 are neoplastic tumour suppressor genes that interact to modulate Rab5 dynamics in Drosophila melanogaster. Dev. Biol. 2014, 385:107-121.
78. Tokuda H., Hirade K., Wang X., Oiso Y., Kozawa O. Involvement of SAPK/JNK in basic fibroblast growth factor-induced vascular endothelial growth factor release in osteoblasts. J. Endocrinol. 2003, 177:101-107.
79. Tokuda H., Kozawa O., Uematsu T. Basic fibroblast growth factor stimulates vascular endothelial growth factor release in osteoblasts: divergent regulation by p42/p44 mitogen-activated protein kinase and p38 mitogen-activated protein kinase. J. Bone Miner. Res. 2000, 15:2371-2379.
80. Uhlirova M., Bohmann D. JNK- and Fos-regulated Mmp1 expression cooperates with Ras to induce invasive tumors in Drosophila. EMBO J. 2006, 25:5294-5304.
81. Vidal M. The dark side of fly TNF: an ancient developmental proof reading mechanism turned into tumor promoter. Cell Cycle 2010, 9:3851-3856.
82. Vidal M., Cagan R.L. Drosophila models for cancer research. Curr. Opin. Genet. Dev. 2006, 16:10-16.
83. Wada K.-I., Itoga K., Okano T., Yonemura S., Sasaki H. Hippo pathway regulation by cell morphology and stress fibers. Development 2011, 138:3907-3914.
84. Weston C.R., Davis R.J. The JNK signal transduction pathway. Curr. Opin. Cell Biol. 2007, 19:142-149.
85. Whitmarsh A.J., Davis R.J. Role of mitogen-activated protein kinase kinase 4 in cancer. Oncogene 2007, 26:3172-3184.
86. Woodfield S.E., Graves H.K., Hernandez J.A., Bergmann A. De-regulation of JNK and JAK/STAT signaling in ESCRT-II mutant tissues cooperatively contributes to neoplastic tumorigenesis. PLoS ONE 2013, 8:e56021.
87. Wu S., Huang J., Dong J., Pan D. Hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with salvador and warts. Cell 2003, 114:445-456.
88. Xia Z., Dickens M., Raingeaud J., Davis R.J., Greenberg M.E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995, 270:1326-1331.
89. Yin F., Yu J., Zheng Y., Chen Q., Zhang N., Pan D. Spatial organization of Hippo signaling at the plasma membrane mediated by the tumor suppressor Merlin/NF2. Cell 2013, 154:1342-1355.
90. Zhao B., Li L., Lei Q., Guan K.L. The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version. Genes Dev. 2010, 24:862-874.